[HTML][HTML] In vitro and ex vivo models in inhalation biopharmaceutical research—advances, challenges and future perspectives
Oral inhalation results in pulmonary drug targeting and thereby reduces systemic side
effects, making it the preferred means of drug delivery for the treatment of respiratory …
effects, making it the preferred means of drug delivery for the treatment of respiratory …
[PDF][PDF] In vitro and ex vivo models in inhalation biopharmaceutical research—advances, challenges and future perspectives
MA Selo, JA Sake, KJ Kim, C Ehrhardt - 2021 - researchgate.net
abstract Oral inhalation results in pulmonary drug targeting and thereby reduces systemic
side effects, making it the preferred means of drug delivery for the treatment of respiratory …
side effects, making it the preferred means of drug delivery for the treatment of respiratory …
In vitro and ex vivo models in inhalation biopharmaceutical research-advances, challenges and future perspectives.
MA Selo, JA Sake, KJ Kim, C Ehrhardt - Advanced Drug Delivery …, 2021 - europepmc.org
Oral inhalation results in pulmonary drug targeting and thereby reduces systemic side
effects, making it the preferred means of drug delivery for the treatment of respiratory …
effects, making it the preferred means of drug delivery for the treatment of respiratory …
In vitro and ex vivo models in inhalation biopharmaceutical research-advances, challenges and future perspectives
MA Selo, JA Sake, KJ Kim… - Advanced drug delivery …, 2021 - pubmed.ncbi.nlm.nih.gov
Oral inhalation results in pulmonary drug targeting and thereby reduces systemic side
effects, making it the preferred means of drug delivery for the treatment of respiratory …
effects, making it the preferred means of drug delivery for the treatment of respiratory …